Platform technology for aerosolbased testing and research
The AeroMP technology provides thee primary advantages over existing products in the aerosol equipment industry:
Comprehensive control. Many firms offer aspects of automation for their aerosol systems, including computer-controlled flow of air into the aerosol system, chamber humidity, monitoring of chamber aerosol concentration, or monitoring of animal respiratory performance. No one provides comprehensive computer control over all relevant aspects of aerosol exposures similar to the AeroMP technology.
Standardization. Because the AeroMP technology brings all aerosol-related parameters under the control of a single software platform, all data are in the same format, and centrally located in the same file. Data streams containing aerosol size, aerosol concentration, animal respiration, air flow, and environmental conditions can be stored in the same format, in the same file, and accessible through the same software packages. This standardization of data collection and storage is ideal for electronic data submission to the U.S. Food and Drug Administration (FDA).
Ease of use. The AeroMP technology makes high quality aerosol work within the reach of any scientist or physician. The single platform concept of the AeroMP technology allows the laboratory aerosol system to be used as an analytical piece of equipment similar to a flow cytometer or HPLC.
Ongoing Success. Thanks to a CCAT-San Bernardino Prototype Development, Testing & Evaluation (PDT&E) award, Biaera was able to sell a Beta unit to Washington University (St. Louis) and was awarded $50,000 in follow-on funding by Maryland Technology Development Co. Biaera also has gotten a purchase order from the University of Washington (Seattle) and the Centers for Disease Control (CDC) in Atlanta. CCAT-San Bernardino has made two market study awards to Biaera.
Biaera has also established a strategic relationship with Frederick Innovative Technology Center for venture incubation, negotiated a service contract with a leading university in the Midwest and completed its National Institutes of Health (NIH) Bio-Defense Small Business Innovation Research (SBIR) Phase I requirements, an essential step for technology adoption and procurement by the Department of Defense (DoD). The firm has a pending equipment purchase contract from the University of Maryland and a pending service contract with a major research university on the west coast.
For more information, please contact:
Juli Gandasatria, Sr. Technology Program Manager
Office of Technology Transfer and Commercialization
E-mail: jgandasa@csusb.edu
Phone: 909-537-7758 / Fax: 909-537-7450